Geogrid Raises Regional Innovation Funding at KRW 16.5B Valuation

양대선 기자 / 기사승인 : 2026-06-22 16:40:43
  • -
  • +
  • 인쇄

 

[메가경제=양대선 기자] Having successfully raised funding from JCH Investment, Geogrid, which is housed at Seoul Startup Hub Seongsu, is now gearing up for global expansion.

 

Geogrid announced on the 22nd that it has successfully secured new funding from JHC Investment.

 

The funding was raised from the ‘Regional Innovation Fund’ operated by JHC Investment. With Geogrid’s growth potential in the water industry and technological competitiveness, its post-money valuation amounted to KRW 16.5 billion.


BLOS (Building Oasis System) is a core solution provided by Geogrid. As a building-integrated smart water purification solution, it is designed to directly connect to the building’s water supply pipes.


BLOS does not rely on any filter changes, chemical treatments, or UV sterilization. It maintains water quality in the building with low-voltage electrolysis, stabilizing the water supply pipes. As it lowers contamination in aged pipes and does not utilize any chemical substances, it eases the burden for both users and the environment.


It has automated continuous water quality monitoring and management on a building-wide scale, adding AI and big data-based water quality management. As it requires no manual intervention or management from the manager, it stands out from traditional purification systems.


Backed by the investment, Geogrid aims to enhance BLOS technology and accelerate its global expansion. It will expand from the private sectors (B2C and B2B) to public sectors, including government and educational facilities (B2G) and the global market. Under the theme of ‘Every building, an oasis’, it is committed to creating an environment where everyone has access to clean water anytime, anywhere.


Kim Ki-hyun, the CEO of Geogrid, noted, “The newly secured investment validates BLOS technology and its growth potential in the water industry. With a technology which transforms the fundamentals of water in buildings, we will redefine the water experience in daily life.”


Officials from JHC Investment said, “Geogrid has successfully demonstrated new possibilities in the water industry with its proprietary technology, which does not rely on chemical substances and UV sterilization. We expect the company to enter the global market.”


Geogrid laid its global market entry foundation by participating in the Seoul Startup Hub Gongdeok global expansion program. The global expansion program offers a variety of supporting initiatives in stages, including market research, networking, and funding matching to promising startups. Through this program, Geogrid visited Japan in April (Tokyo and Kobe) and Silicon Valley, North America, in May.


The company received a wide range of supports from the global expansion program, including local market research, market entry consulting, participation in overseas exhibitions, networking and IR pitching with local enterprises and investors, and financial support for commercialization. It has broadened its reach in the global market by participating in major global exhibitions and networking events, such as ‘SusHi Tech Tokyo 2025’ and ‘Tech Beat Shizuoka 2025’.

[저작권자ⓒ 메가경제. 무단전재-재배포 금지]

뉴스댓글 >

최신기사

1

"섬에도 의사가 온다"…일동 새로엠에스, '비대면 섬 닥터' 승선
[메가경제=김민준 기자] 일동제약그룹의 헬스케어 플랫폼 계열사 새로엠에스가 도서·어촌 지역 의료 사각지대를 해소하기 위한 정부 사업에 참여한다. 비대면 진료 키오스크를 공급하고 의료기관·약국 연계 시스템을 구축해 섬 주민들의 의료 접근성을 높인다는 계획이다. 새로엠에스는 해양수산부가 추진하는 '2026년도 어촌 복지 버스(어복 버스)'

2

"세노바메이트 다음은 AI"…SK바이오팜, 인실리코와 CNS 공략
[메가경제=김민준 기자] SK바이오팜이 생성형 인공지능(AI)을 활용한 신약개발에 본격적으로 뛰어든다. 아시아 대표 AI 신약개발 기업인 인실리코 메디슨과 협력해 중추신경계(CNS) 질환 치료제 후보물질을 발굴하고, AI 기반 연구개발(AIDD) 역량을 내재화하겠다는 전략이다. SK바이오팜은 미국 보스턴에서 열린 '2026 바이오 인터내셔널

3

유전독성 넘은 제프티…현대바이오, '만능 항바이러스제' 시대 가속화
[메가경제=김민준 기자] 현대바이오사이언스가 개발 중인 범용 항바이러스제 후보물질 '제프티(Xafty)'가 비임상 유전독성 시험에서 안전성을 입증했다. 숙주세포를 표적으로 하는 항바이러스제 개발 과정에서 가장 큰 걸림돌로 꼽혀온 유전독성 문제를 넘어서면서 미국에서 추진 중인 호흡기 바이러스 통합 임상 진입에도 속도가 붙을 전망이다. 현

HEADLINE

더보기

트렌드경제

더보기